CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 982 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01377402
NCT01377402N/ACompleted

ARgentinean Risk Assessment Registry in Acute Coronary Syndrome; the ARRA-RACS Study.

Helse Stavanger HF·observational·Posted Jun 21, 2011·Updated May 2, 2017

In Brief

An observational study for Chest Pain and 3 related conditions. Completed, enrolled 982 participants across 10 sites in 2 countries.

Detailed Summary

The first aim of this trial is to assess the long-term prognostic value of Omega-3 index, which is a measure of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) relative to other fatty acids in the erythrocyte membrane, in an unselected, regional multicenter observational study of 982 chest pain patients admitted to the emergency unit, employing blood samples collected at admission. The second purpose of this study is to evaluate the prognostic utility of vitamin D in the same population. The third purpose of this study is to assess the incremental prognostic value of B-type natriuretic peptide (BNP) and high-sensitive C-reactive protein (hsCRP).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesArgentina, Norway

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 21, 2011
Enrollment StartNov 1, 2005
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 15.0 years ago